A 38-year-old man comes to the clinic complaining of recurrent abdominal pain for the past 2 months. He reports a gnawing, dull pain at the epigastric region that improves with oral ingestion. He has been taking calcium carbonate for the past few weeks; he claims that “it used to help a lot but it’s losing its effects now.” Laboratory testing demonstrated increased gastrin levels after the administration of secretin. A push endoscopy visualized several ulcers at the duodenum and proximal jejunum. What characteristics distinguish the jejunum from the duodenum?

Lack of submucosal Brunner glands

A scientist is studying the mechanism by which the gastrointestinal system coordinates the process of food digestion. Specifically, she is interested in how distension of the lower esophagus by a bolus of food changes responses in the downstream segments of the digestive system. She observes that there is a resulting relaxation and opening of the lower esophageal (cardiac) sphincter after the introduction of a food bolus. She also observes a simultaneous relaxation of the orad stomach during this time. Which of the following substances is most likely involved in the process being observed here?

Vasoactive intestinal polypeptide

A 38-year-old man comes to the physician because of an 8-month history of upper abdominal pain. During this period, he has also had nausea, heartburn, and multiple episodes of diarrhea with no blood or mucus. He has smoked one pack of cigarettes daily for the past 18 years. He does not use alcohol or illicit drugs. Current medications include an antacid. The abdomen is soft and there is tenderness to palpation in the epigastric and umbilical areas. Upper endoscopy shows several ulcers in the duodenum and the upper jejunum as well as thick gastric folds. Gastric pH is < 2. Biopsies from the ulcers show no organisms. Which of the following tests is most likely to confirm the diagnosis?

24-hour esophageal pH monitoring

Serum vasoactive intestinal polypeptide level

A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?

"Can you tell me more about the symptoms you have been experiencing?"

"Does the diarrhea typically precede the constipation, or vice-versa?"

"Is the diarrhea foul-smelling?"

"Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"

"Are the symptoms worse in the morning or at night?"

Gastric secretion regulation for USMLE Step 2 CK: High-Yield Physiology Lessons

Gastric Gland Cells - The Stomach's Crew

Gastric Gland Cells and Secretions

Cell Type	Secretion(s)	Key Function(s)
Mucous Cells	Mucin, Bicarbonate	Protects stomach lining from acid
Parietal Cells	Gastric Acid (HCl), Intrinsic Factor (IF)	Kills microbes; digests food; required for Vitamin B12 absorption
Chief Cells	Pepsinogen, Gastric Lipase	Precursor to pepsin for protein digestion; fat digestion
G Cells	Gastrin	Stimulates acid secretion by parietal cells

Secretion Phases - Thinking, Tasting, Digesting

Gastric secretion is regulated in three phases, aligning acid release with the presence of food. The initial phases are stimulatory, while the final phase is primarily inhibitory.

Cephalic Phase: Triggered by thought, sight, or taste of food. Mediated entirely by the vagus nerve, accounting for ~30% of total secretion.
Gastric Phase: Activated by food in the stomach (distension, peptides). Accounts for ~60% of secretion, driven by gastrin and vago-vagal reflexes.
Intestinal Phase: Chyme entering the duodenum initiates inhibitory signals (Secretin, CCK) to ↓ acid.

⭐ The intestinal phase is crucial for negative feedback. Release of Secretin in response to duodenal acid ($H^+$) is the most potent inhibitor of gastrin release and gastric acid secretion.

Molecular Regulators - The Chemical Orchestra

Stimulatory Pathways (↑ H⁺) 📌 Mnemonic: All Good Health (ACh, Gastrin, Histamine).
- Acetylcholine (ACh): Released from vagal nerve endings.
  - Binds M3 receptors on parietal cells.
  - Pathway: $G_q \rightarrow \uparrow IP_3/Ca^{2+}$.
- Gastrin: Secreted by G-cells in the antrum.
  - Binds CCK2 receptors on parietal and ECL cells.
  - Pathway: $G_q \rightarrow \uparrow IP_3/Ca^{2+}$.
  - Potently stimulates histamine release.
- Histamine: Released from Enterochromaffin-like (ECL) cells.
  - Binds H2 receptors on parietal cells.
  - Pathway: $G_s \rightarrow \uparrow cAMP$.
Inhibitory Pathways (↓ H⁺)
- Somatostatin: Secreted by D-cells.
  - Acts via $G_i$ to ↓cAMP.
  - Inhibits G-cells, ECL cells, and parietal cells.
- Prostaglandins (PGE₂):
  - Act via $G_i$ to ↓cAMP.
  - Cytoprotective: ↑ mucus and $HCO_3^-$ secretion.

⭐ Potentiation: Histamine potentiates the effects of gastrin and ACh. The combined effect of all three is greater than the sum of their individual effects, a key principle for drug action (e.g., H2 blockers).

Clinical Tie-ins - When Glands Go Rogue

Zollinger-Ellison Syndrome (ZES): Caused by a gastrin-secreting tumor (gastrinoma), often in the pancreas or duodenum.
- Leads to unrelenting acid production (↑↑ HCl), causing multiple, refractory, or unusually located (e.g., jejunal) peptic ulcers.
- Presents with abdominal pain, chronic diarrhea (pancreatic enzyme inactivation), and heartburn.
- Associated with Multiple Endocrine Neoplasia type 1 (📌 MEN1).
Pernicious Anemia: Autoimmune gastritis targeting parietal cells.
- Results in ↓ HCl (achlorhydria) and loss of intrinsic factor (IF).
- IF deficiency causes vitamin B12 malabsorption, leading to megaloblastic anemia and neurological symptoms.
- Achlorhydria stimulates G-cell hyperplasia, causing ↑ serum gastrin.

⭐ In ZES, a secretin stimulation test is diagnostic. Normally, secretin inhibits G-cell gastrin release, but it paradoxically stimulates gastrin release from a gastrinoma.

High-Yield Points - ⚡ Biggest Takeaways

Vagal stimulation (ACh) is a key driver, directly acting on parietal cells and stimulating gastrin and histamine release.

Gastrin from G cells potently stimulates acid, primarily by triggering histamine release from ECL cells.

Histamine is the strongest direct stimulant of parietal cells via H2 receptors.

Somatostatin from D cells is the universal inhibitory signal for parietal, G, and ECL cells.

Low gastric pH (<3) stimulates somatostatin release, providing essential negative feedback.

Prostaglandins are cytoprotective, inhibiting acid while stimulating mucus/bicarbonate secretion.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play